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Abstract
Background: Liver regeneration following 70 % partial hepatectomy (PH) requires the coordinated expression of
soluble mediators produced by macrophages. Monocyte chemoattractant protein-1 (MCP-1) is a potent stimulus of
monocyte recruitment and macrophage activation. The goal of this study was to determine how MCP-1 contributes
to liver regeneration.
Methods: PH was performed on anesthetized C57Bl/6 (wild type) and MCP-1 knockout mice, and macrophage-produced
cytokines and hepatocyte proliferation were measured.
Results: In wild type mice, hepatic MCP-1 protein levels increased 4–6 h after PH, and elevated plasma MCP-1 levels were
detected 12 h after PH. Hepatocyte proliferation was comparable in MCP-1 knockout and wild type mice, as
was the expression of macrophage-derived cytokines, TNFα and IL-6, and levels of phosphorylated STAT3. The
number of CCR2+ cells in the liver was similar in MCP-1 knockout and wild type mice, which suggests that
other chemokines may recruit CCR2+ cells in the absence of MCP-1. Studies with CCR2 knockout mice revealed
that hepatocyte proliferation was suppressed ~40 % compared to wild type mice 36 h after PH, but proliferation and
liver-body-weight ratios were similar at 48 h.
Conclusion: These findings suggest that MCP-1 is not required for PH-induced liver regeneration, yet the role of CCR2
warrants further study.
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Background
Liver regeneration is a complex physiological process
that is influenced by soluble mediators, including cyto-
kines, growth factors and hormones [1]. One of the best-
studied models of liver regeneration is based on 70 %
partial hepatectomy (PH), in which two-thirds of the
liver is surgically resected. Whereas hepatocytes in
healthy liver are normally quiescent, removal of a sub-
stantial portion of the liver induces compensatory
hyperplasia as remaining hepatocytes enter and progress
through the cell cycle to restore original organ mass [2].
Hepatocyte proliferation is accompanied by the activa-
tion of nonparenchymal cells in the liver, which produce
cytokines and growth factors that facilitate hepatocyte
cell cycle progression [1].
Liver macrophages (Kupffer cells) are particularly im-
portant for the early priming phase of liver regeneration.
Following PH, Kupffer cells become activated and pro-
duce tumor necrosis factor (TNF)-α, which functions
through an autocrine pathway to activate nuclear factor
kappa B (NF-kB) and stimulate interleukin (IL)-6 pro-
duction. Kupffer cell-derived IL-6 acts on hepatocytes to
activate the signal transducer and activator of
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transcription-3 (STAT3) pathway, which upregulates
immediate-early gene expression and promotes respon-
siveness to growth factors [3, 4]. The importance of
Kupffer cell-derived cytokine production is underscored
by findings that liver regeneration is impaired in the ab-
sence of IL-6 [5], TNF-receptor-1 [6, 7] and NF-kB sig-
naling [8, 9]. Furthermore, several studies report that
hepatocyte DNA synthesis is either reduced or delayed
when Kupffer cells are selectively depleted by adminis-
tration of liposome-encapsulated dichloromethylene
diphosphonate and point to decreased production of
proliferative cytokines as at least one possible explan-
ation [8, 10, 11].
The stimulus that initiates Kupffer cell activation and
subsequent cytokine production during liver regener-
ation has not been identified. It has been proposed that
enteric lipopolysaccharide (LPS) or other microbial
products in the portal circulation may be responsible for
activating cytokine production in these cells [12]. Along
these lines, several studies report modulation of IL-6
levels after PH in mice that lack Myd88, an adaptor pro-
tein for the Toll-like (TLR)/IL-1 family of receptors that
detect microbial components [13–15]. However, the
finding that type I interferon is not required for liver re-
generation suggests that microbial products are not a re-
quired stimulus for macrophage activation and cytokine
production [15]. Hence, mechanisms of Kupffer cell acti-
vation during liver regeneration remain unclear.
In the present study, we investigated the possibility
that the production of Kupffer cell-derived cytokines
and subsequent liver regeneration are influenced by
monocyte chemoattractant protein-1 (MCP-1 or CCL2),
a well-known, potent stimulus of macrophage recruit-
ment and activation [16–18]. MCP-1 is a small, secreted
protein in the CC family of chemokines that contain
two, adjacent cysteine residues [19]. Regulated at the
transcriptional level, hepatic MCP-1 expression is in-
duced by a variety of stimuli, including lipopolysacchar-
ide, TNFα and IL-1 [20], as well as toxicants such as
carbon tetrachloride and D-galactosamine [1]. In the
liver, MCP-1 is produced by hepatic stellate cells as well
as biliary epithelial cells and perisinusoidal cells [20, 21].
MCP-1 expression has been shown to increase during
chronic hepatitis, inflammation and fibrosis [20–23].
Furthermore, it has been reported that MCP-1 expres-
sion directly correlates with the number of infiltrating
monocytes and macrophages in the liver [21], and inacti-
vation of MCP-1 attenuates liver injury by inhibiting
macrophage recruitment [24, 25].
Given the crucial role of macrophage-derived cyto-
kines during liver regeneration, we hypothesized that
MCP-1 is important for this early, priming phase of PH-
induced regeneration. In the present study, we used
MCP-1 knockout mice, as well as C-C chemokine
receptor type 2 (CCR2) knockout mice, to determine
the significance of MCP-1 to the early priming phase of
liver regeneration, based on endpoints of macrophage-
produced cytokines and hepatocyte proliferation.
Methods
Animals
Female C57Bl/6 (wild type), MCP-1 knockout (strain
B6.129S4-Ccl2tm1Rol/J), and CCR2 knockout (strain
B6.129S4-Ccr2tm1Ifc/J) mice were purchased from the
Jackson Lab (Bar Harbor, ME) and used at 8–9 weeks of
age. MCP-1 and CCR2 knockout mice are fertile and
display no gross physical or behavioral abnormalities.
Furthermore, numbers of macrophages (peritoneal,
alveolar, and Kupffer cells) in these mice are similar to
levels found in wild type mice [26]. Mice were housed in
a temperature-controlled facility on a 12-h light/dark
cycle with unlimited access to food and water. Wild type
and MCP-1 knockout mice were anesthetized with in-
haled isoflurane, and 70 % PH was performed as previ-
ously described [27]. After euthanasia, blood was
collected at the axillary plexus and plasma recovered by
centrifugation. Remnant liver tissue was collected and
processed as described below. Mice that did not receive
PH were used as controls, and data from these animals
are included on graphs at the “0 h post-PH” time point.
The experimental protocol was approved by the Animal
Studies Subcommittee and the Research and Develop-
ment Committee of the Boise Veterans Affairs Medical
Center (Boise, ID), where the animals were housed. All
animals received humane care according to the criteria
outlined in the “Guide for the Care and Use of Labora-
tory Animals” prepared by the National Academy of Sci-
ences and published by the National Institutes of Health.
Measurement of MCP-1 levels
To measure hepatic MCP-1 mRNA levels, total RNA
was isolated from frozen liver tissue using an RNeasy
Mini Kit (Qiagen, Valencia, CA) according to the manu-
facturer’s protocol. cDNA was synthesized using Super-
Script II reverse transcriptase (Invitrogen, Carlsbad,
CA). Transcript levels were measured as previously de-
scribed [27] by quantitative real-time PCR (qRT-PCR) at
the Molecular Genomics Core at the University of Texas
Medical Branch (Galveston, TX). To measure MCP-1
protein levels in the liver, frozen liver tissue was homog-
enized in PBS containing 0.5 % Triton X-100, 0.05 % so-
dium azide, and protease inhibitors. MCP-1 levels were
measured in liver homogenates by enzyme-linked im-
munosorbent assay (ELISA; Thermo Scientific Pierce,
Rockford, IL) and expressed as pg per mg liver protein,
based on a modified Lowry protein assay (Bio-Rad,
Hercules, CA). Plasma levels of MCP-1 were measured
using a Cytometric Bead Array (BD Biosciences, San
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Diego, CA) according to the manufacturer’s instructions.
Unpooled plasma samples were run in duplicate.
Measurement of TNFα and IL-6 by ELISA
Levels of TNFα and IL-6 were measured in unpooled
plasma samples using ELISA kits (Pierce Biotech, Rockford,
IL). The assays were performed according to the manufac-
turer’s instructions, and all samples were run in duplicate.
The lower limit of detection for the assays was 50 pg/ml.
Measurement of STAT3 Activation by western blot
Frozen liver tissue was mechanically homogenized as
previously described [27]. Cellular debris was pelleted at
10,000 × g, and protein concentration was determined
by using a Lowry protein assay (Bio-Rad, Hercules, CA).
Homogenates (25–50 μg protein/lane) were fractionated
by sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE) and transferred to polyvinylidene
difluoride membranes for western blot analysis with
anti-STAT3 and anti-phosphorylated STAT3 antibodies
(Cell Signaling Technology, Danvers, MA).
BrdU labeling and detection
To measure hepatocyte proliferation, mice were injected
intraperitoneally with 50 mg/kg 5-bromo-2′-deoxyuri-
dine (BrdU; Sigma-Aldrich, St. Louis, MO) 2 h prior to
euthanasia. In a separate experiment, continuous BrdU
labeling was achieved by administering BrdU in the
drinking water (0.8 mg/ml). Water bottles containing
BrdU were protected from light and replenished daily
until mice were euthanized 6 days postoperatively. After
euthanasia, fresh liver tissue was fixed in UltraLight™
fixative (Bi-Biomics, Nampa, ID), paraffin-embedded,
and processed for immunohistochemical staining. Tissue
sections (5-um) were incubated with a biotinylated anti-
BrdU antibody (Invitrogen, Carlsbad, CA) followed by
avidin-conjugated horseradish peroxidase and the sub-
strate 3,3′-diaminobenzidine (DAB). Sections were
counterstained with hematoxylin. For each animal, at
least five random 400X fields were examined, and a
total of 800–1000 nuclei were counted. The number
of brown (DAB)-stained nuclei (BrdU+) was expressed
as a percentage of total number of nuclei.
Detection of CCR2+ cells by flow cytometry
Nonparenchymal cells were isolated from the liver and an-
alyzed by flow cytometry. Briefly, livers were perfused with
Hank’s Buffered Salt Solution (HBSS) containing 50 mM
ethylenediaminetetraacetic acid (EDTA), transferred to
RPMI 1640 with 2.5 % FBS, minced into a slurry, and
poured through a nylon cell strainer. Samples were centri-
fuged at 60 × g for 1 min at room temperature (RT), and
pellets containing hepatocytes were discarded. Samples
were then centrifuged at 500 × g for 10 min at RT.
Resulting pellets were re-suspended in Percoll in RPMI
1640 without FBS and centrifuged at 850 × g, 30 min,
at room temperature. Pellets were depleted of red blood
cells by hypotonic lysis, and remaining cells were resus-
pended in PBS containing 1 % fetal bovine serum. Cells
were then incubated with Fc-Receptor Block (BD Bio-
sciences, San Jose, CA) for 10 min before staining with
a rabbit monoclonal anti-CCR2 antibody (Novus, Little-
ton, CO) followed by a FITC-conjugated goat anti-rabbit
antibody (BD Biosciences, San Diego, CA). Stained cells
were analyzed on an Accuri C6 flow cytometer (Ann
Arbor, MI). At least 50,000 events (viable cells) were col-
lected from unpooled samples and analyzed using Accuri
CFlow Plus software.
Statistical analysis
Data were analyzed using Prism (version 6.0, GraphPad
Software, San Diego, CA). Data were evaluated by a Stu-
dent’s t-test, one-way analysis of variance (ANOVA)
followed by a Dunnett’s post-hoc test, or by two-way
ANOVA and Bonferroni post-hoc test, depending on the
number of variables under consideration. Data were
considered significantly different at p ≤ 0.05.
Results
MCP-1 levels increase after PH
To examine MCP-1 production after PH, MCP-1 mRNA
levels were quantified in the remnant liver, and protein
levels were measured in liver homogenates and plasma.
Hepatic MCP-1 mRNA levels peaked 90 min after PH
(Fig. 1a), followed by increased MCP-1 protein expres-
sion in the regenerating liver 4 and 6 h after PH (Fig. 1b).
A four-fold increase in circulating MCP-1 was detected
in the plasma 12 h after PH (Fig. 1c).
MCP-1 is not required for the production of TNFα or IL-6
during liver regeneration
During the priming phase of liver regeneration, the pro-
duction of TNFα and IL-6 is attributed to activated
Kupffer cells [1]. Kupffer cells express the MCP-1 recep-
tor, CCR2, and have been shown to become activated in
response to MCP-1 in other model systems [22]. Hence,
we hypothesized that MCP-1 may influence the produc-
tion of Kupffer cell-derived cytokines during liver regen-
eration. However, measurement of plasma cytokine
levels revealed no difference in TNFα or IL-6 production
between wild type and MCP-1 knockout mice (Fig. 2).
Hepatic mRNA levels of these cytokines were below the
limit of detection (data not shown).
MCP-1 is not required for priming of hepatocytes during
liver regeneration
The production of TNFα and IL-6 by Kupffer cells is im-
plicated in priming hepatocytes for cell cycle progression
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[28]. Upon binding to its cognate receptor on hepato-
cytes, IL-6 activates STAT3 signaling pathways, leading
to gene expression that facilitates hepatocyte prolifera-
tion. Hence, STAT3 activation is a pivotal step in regen-
eration that is likely to be dependent on macrophage
activation. Our results indicate that hepatic levels of
phosphorylated STAT3 increased 6 and 12 h after PH in
both wild type and MCP-1 knockout mice, suggesting
that MCP-1 is not necessary for hepatocyte priming dur-
ing liver regeneration (Fig. 3).
MCP-1 is not required for hepatocyte proliferation after PH
Finally, we investigated the ramifications of MCP-1
production on the regenerative capacity of the liver.
No differences in liver-body weight ratios were de-
tected between wild type and MCP-1 knockout mice
(Fig. 4a). Proliferation was measured using BrdU,
which is a thymidine analog that is incorporated into
newly synthesized DNA. Pulse labeling with BrdU re-
vealed that robust hepatocyte proliferation occurred
36 and 48 h after PH in wild type mice and was not
suppressed in MCP-1 knockout mice (Fig. 4b). Like-
wise, continuous BrdU administration revealed no
overt differences in BrdU incorporation in the regen-
erating liver of wild type and MCP-1 knockout mice
6 days post-PH (Fig. 4c & d).
MCP-1 is not required for recruitment of CCR2+ cells to
the regenerating liver
In addition to activating resident macrophages, MCP-1
may also recruit cells, such as bone-marrow-derived
monocytes, to the damaged liver [29, 30]. To investigate
the possibility that cell recruitment was diminished in
the absence of MCP-1, the prevalence of CCR2+ cells in
the regenerating liver was measured using flow cytometry.
The percent and total number of CCR2+ non-parenchymal
cells in the liver of wild type and MCP-1 knockout mice
was comparable 12 h after PH (Fig. 5).
Hepatocyte proliferation is transiently suppressed in
CCR2 knockout mice
While MCP-1 is the most potent ligand of CCR2, there
is redundancy in chemokine signaling such that MCP-3
and MCP-5 also bind this receptor, which could explain
Fig. 1 MCP-1 levels increase after PH. a MCP-1 mRNA levels in the regenerating liver at the indicated times after PH. MCP-1 mRNA levels (mean
+/− SEM) are expressed as fold-induction relative to expression of 18S rRNA in the same samples. Data were measured in three randomly selected
samples at each time point, and each sample was run in duplicate. b MCP-1 protein levels in the liver after PH. MCP-1 levels (mean +/− SEM) in
liver homogenates were normalized to the total amount of protein in each sample (n = 5–6). c MCP-1 protein levels (mean +/− SEM) in
the plasma after PH (n = 5–6). * p < 0.05 when compared to 0-h group based on one-way ANOVA followed by Dunnett’s test
Fig. 2 Levels of Kupffer cell-derived cytokines are similar in wild type
and MCP-1 knockout mice. Data represent plasma levels (mean
+/− SEM) of TNFα and IL-6 in wild type and MCP-1 knockout
mice at the indicated times after PH. Cytokines were measured
in unpooled plasma samples by ELISA (n = 5–6) and run in duplicate.
Means at each time point were not statistically significant from each
other based on two-way ANOVA
Fig. 3 MCP-1 is not required for STAT3 activation during liver
regeneration. Western blot analysis of STAT3 and phosphorylated-
STAT3 proteins in the regenerating liver of wild type and MCP-1
knockout mice at the indicated times after PH (20 μg protein/lane)
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why liver regeneration was not impaired in the absence
of MCP-1. To investigate the collective contribution of
all CCR2 chemokines to regeneration, we compared PH-
induced hepatocyte proliferation between CCR2 knock-
out and wild type mice. As shown in Fig. 6, levels of
BrdU incorporation were reduced by about 40 % in
CCR2 knockout mice 36 h after PH, although no sta-
tistically significant suppression was observed at 48 h.
Reduced hepatocyte proliferation at 36 h did not co-
incide with diminished liver-body weight ratios, which
remained similar in CCR2 knockout and wild type
mice at every time point tested.
Discussion
Macrophage activation and the production of cytokines
are a crucial component of the early phase of liver regen-
eration following PH [1]. Given the well-characterized role
of MCP-1 in activating macrophages and promoting
macrophage infiltration, we hypothesized that MCP-1
would be important for this early phase of PH-induced
liver regeneration. However, data presented herein refute
this hypothesis and demonstrate that, despite increased
hepatic levels of MCP-1 after PH, this chemokine is not
required for the production of macrophage-derived
Fig. 4 MCP-1 is not required for hepatocyte proliferation after PH. a Liver-body weight ratios (mean +/− SEM) of wild type and MCP-1 knockout
mice at the indicated times after PH. Sample size varied due to the limited availability of MCP-1 knockout mice. The numbers above the data bars
indicate how many MCP-1 knockout mice were used at each time point; an identical number of wild-type mice were used at that same time point.
b Percentage (mean +/− SEM) of BrdU+ hepatocyte nuclei from wild type or MCP-1 knockout mice at the indicated times after PH. Mice were pulsed
with BrdU 2 h prior to euthanasia at the indicated time points (n = 6 at 0 and 24 h; n = 10 at 36 and 48 h). c Representative BrdU incorporation in
regenerating liver tissue from wild type and MCP-1 knockout mice 6 days after PH; BrdU was added to the drinking water continuously for 6 days.
d Cumulative BrdU incorporation in the regenerating liver of wild type and MCP-1 knockout mice administered BrdU in their drinking water for 6 days
post-PH. Data represent the percentage (mean +/− SEM) of BrdU+ hepatocyte nuclei from 4 wild-type mice and 4 MCP-1 knockout mice. Means at
each time point were not statistically significant from each other based on two-way ANOVA (Fig. 4 a, b) or Student’s t-test (Fig. 4 d)
Fig. 5 MCP-1 is not required for recruitment of CCR2+ cells to the
regenerating liver. Flow cytometry was used to measure CCR2
expression in non-parenchymal cells isolated from the regenerating
liver of wild type and MCP-1 knockout mice 12 h after PH. Data represent
the mean percentage and number (±SEM) of CCR2+ cells (n= 4). Means
were not statistically significant based on Student’s t-test
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inflammatory cytokines or for hepatocyte proliferation in
the regenerating liver.
Increased MCP-1 expression has been observed in nu-
merous models of liver injury and disease, such as ad-
ministration of concanavalin A, carbon tetrachloride,
and acetaminophen [25, 31, 32]. Our results indicate
that hepatic MCP-1 transcript levels increased just
90 min after PH, which corroborates another report
[33]. Elevated plasma levels of MCP-1 were detected at
12 h and were only slightly above basal levels. It is pos-
sible that plasma levels peaked prior to this time, as it
was reported elsewhere that serum MCP-1 levels were
robustly elevated at 3 and 6 h after PH in C57Bl/6 mice
[34]. However, another study reported only scant plasma
levels of MCP-1 in DBA1 mice 4 h post-PH [35].
Although Kupffer cells are a known source of MCP-1,
it is likely that multiple cellular sources of MCP-1 exist
in the regenerating liver [36]. For instance, in a rat
model of PH-induced liver regeneration, elevated MCP-
1 mRNA levels were detected in hepatocytes, biliary epi-
thelial cells, sinusoidal endothelial cells, Kupffer cells, pit
cells, and hepatic oval cells [37]. It is also possible that
MCP-1 production could be attributed to inflammatory
cells that infiltrate the liver after PH, such as bone
marrow-derived monocytes/macrophages. In fact, an
intriguing report by Crane et. al. indicates that F4/80+
bone marrow cells are an abundant source of MCP-1, as
well as MCP-3 and MCP-5, during infection with mur-
ine cytomegalovirus [38]. Hence, during PH-induced
liver regeneration, bone-marrow-derived monocytes
could be an important source of MCP-1 in the bone
marrow, during transit to the liver, or upon infiltration
into hepatic tissue.
MCP-1 expression has been shown to directly correl-
ate with the number of infiltrating monocytes and mac-
rophages in the liver [21], and inactivation of MCP-1
reportedly attenuates liver injury by inhibiting macro-
phage recruitment [24, 25]. However, we found no dif-
ference in expression of the macrophage marker F4/80
in wild type and MCP-1 knockout mice (data not
shown). Furthermore, plasma levels of TNFα and IL-6
were also similar, which indicates that macrophage acti-
vation was likely unaffected by the absence of MCP-1.
Studies with bone marrow chimeric mice attribute the
PH-induced elevation in circulating levels of IL-6 and
TNFα to cells of bone marrow-derived resident macro-
phages [28, 39]. IL-6 and TNFα signaling pathways are
important to the initiation of hepatocyte proliferation
after PH, as regeneration is impaired and survival is re-
duced in IL-6-deficient mice and TNF receptor 1-
deficient mice subjected to PH [5–7]. Because no
changes in IL-6 were detected between wild type and
MCP-1 knockout mice, it would appear that resident
macrophages cells are unaffected by the absence of
MCP-1 during PH-induced liver regeneration.
During the priming phase of regeneration, IL-6 acti-
vates STAT3, which upregulates immediate-early gene
expression in hepatocytes and promotes responsiveness
to growth factors [3, 4]. Given that levels of STAT3
phosphorylation were similar in wild type and MCP-1
knockout mice, it stands to reason that hepatocyte prim-
ing proceeds sufficiently despite the absence of MCP-1.
Furthermore, continuous and pulse BrdU labeling re-
vealed similar levels of hepatocyte proliferation in wild
type and MCP-1 knockout mice. The observation that
liver-body weight ratios were unchanged between wild
type and MCP-1 knockout mice further establishes that
MCP-1 is dispensable for liver regeneration.
Results from this study demonstrate comparable num-
bers of CCR2+ cells in the liver of wild type and MCP-1
knockout mice, causing us to speculate that other CCR2
ligands, such as MCP-3 or MCP-5, could compensate
for the absence of MCP-1. However, the observation that
liver regeneration was not overtly suppressed in CCR2
knockout mice renders this notion somewhat irrelevant.
In CCR2 knockout mice, hepatocyte proliferation was
suppressed 36 h post-PH. However, this did not coincide
with decreased liver-body weight ratios, and BrdU in-
corporation was comparable between CCR2 knockout
Fig. 6 Hepatocyte proliferation is transiently suppressed in CCR2-
deficient mice. a Percentage (mean +/− SEM) of BrdU+ hepatocyte
nuclei from wild type or CCR2 knockout mice at the indicated times
after PH. Mice were pulsed with BrdU 2 h prior to euthanasia at
the indicated time points (n = 4). b Liver-body weight ratios
(mean +/− SEM) of wild type and CCR2 knockout mice at the
indicated times after PH. * p <0.05 when compared to wild type
mice at same time point based on two-way ANOVA followed by
Bonferroni’s post-hoc test
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and wild type mice at 48 h post-PH. The suppression at
36 h may result from diminished macrophage activity in
the absence of CCR2, either through decreased mono-
cyte recruitment to the liver or reduced activation of
resident Kupffer cells. It has been shown that CCR2 acti-
vation in the bone marrow initiates the egress of CCR2+
monocytes into the circulation and to the liver [38]. This
same report revealed that CCR2+ Ly6Chigh inflammatory
monocytes/macrophages accumulated in the bone mar-
row during MCMV infection, and that the number of in-
flammatory monocytes/macrophages was diminished in
CCR2-deficient mice. Hence, it is possible that monocyte
recruitment and/or macrophage activation is reduced in
CCR2 knockout mice, leading to a transient suppression
of hepatocyte proliferation.
Conclusions
Liver regeneration is important for maintaining organ
mass and function following acute or chronic liver in-
jury. Despite the potent regenerative capacity of the liver,
insufficient regeneration remains a significant impedi-
ment to recovery from liver disease. Identifying mecha-
nisms that initiate liver regeneration will lead to the
development of new therapeutic strategies to enhance
recovery from liver disease. Results presented herein rule
out a role for the potent macrophage activator, MCP-1,
in driving the priming phase of liver regeneration.
Furthermore, the observation that regeneration was
largely unaffected by the absence of CCR2 indicates
that other chemokines that signal through this recep-
tor are probably not crucial regulators of macrophage
activation in the regenerating liver. Initiation of re-
generation is presumably tightly regulated not only be
proinflammatory cytokines, but by other factors that
have yet to be identified.
Acknowledgements
We thank Dietric Hennings and Charissa McClannahan for their technical
assistance and Dr. Kenneth Cornell for assistance with manuscript preparation.
Funding
This project was supported by the National Institutes of Health grants
R15DK088749 and 1UL1RR025014. Additional support was provided by Institutional
Development Awards (IDeA) from the National Institute of General Medical
Sciences of the National Institutes of Health [P20GM103408, P20GM109095].
Availability of data and material
All data generated or analyzed during this study are included in this
published article.
Authors’ contributions
SLW, CLL, and KAM conceived and designed the research. SLW and SLD
completed the experimental work and data collection. SLW, SLD, CLL, and
KAM conducted the data analysis and interpretation. SLW and KAM wrote the
manuscript. All authors read and approved the final version of the manuscript.
Competing interests




All animal experiments were approved by the Animal Studies Subcommittee
and the Research and Development Committee of the Boise Veterans Affairs
Medical Center (Boise, ID), where the animals were housed. Experiments
were conducted in compliance with the regulations and institutional
policies that govern animal care and use.
Received: 30 December 2015 Accepted: 16 August 2016
References
1. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol.
2004;5:836–47.
2. Michalopoulos GK. Liver regeneration. J Cell Physiol. 2007;213:286–300.
3. Terui K, Ozaki M. The role of STAT3 in liver regeneration. Drugs Today. 2005;
41:461–9.
4. Li W, Liang XP, Kellendonk C, Poli V, Taub R. STAT3 contributes to the
mitogenic response of hepatocytes during liver regeneration. J Biol Chem.
2002;277:28411–7.
5. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V,
Taub R. Liver failure and defective hepatocyte regeneration in interleukin-6-
deficient mice. Science. 1996;274:1379–83.
6. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by
tumor necrosis factor: deficient liver regeneration in mice lacking type I
tumor necrosis factor receptor. Proc Natl Acad Sci U S A. 1997;94:1441–6.
7. Yamada Y, Webber EM, Kirillova I, Peschon JJ, Fausto N. Analysis of liver
regeneration in mice lacking type 1 or type 2 tumor necrosis factor
receptor: requirement for type 1 but not type 2 receptor. Hepatology. 1998;
28:959–70.
8. Abshagen K, Eipel C, Kalff JC, Menger MD, Vollmar B. Loss of NF-kappa B
activation in Kupffer cell-depleted mice impairs liver regeneration after
partial hepatectomy. Am J Physiol Gastrointest Liver Physiol. 2007;292:
G1570–7.
9. Iimuro Y, Nishiura T, Hellerbrand C, Behrns KE, Schoonhoven R, Grisham JW,
Brenner DA. NF kappa B prevents apoptosis and liver dysfunction during
liver regeneration. J Clin Investig. 1998;101:802–11.
10. Meijer C, Wiezer MJ, Diehl AM, Yang SQ, Schouten HJ, Meijer S, van Rooijen
N, van Lambalgen AA, Dijkstra CD, van Leeuwen PAM. Kupffer cell depletion
by CI2MDP-liposomes alters hepatic cytokine expression and delays liver
regeneration after partial hepatectomy. Liver. 2000;20:66–77.
11. Takeishi T, Hirano K, Kobayashi T, Hasegawa G, Hatakeyama K, Naito M. The
role of Kupffer cells in liver regeneration. Arch Histol Cytol. 1999;62:413–22.
12. Cornell RP, Liljequist BL, Bartizal KF. Depressed liver-regeneration after
partial-hepatectomy of germ-free, athymic and lipopolysaccharide-resistant
mice. Hepatology. 1990;11:916–22.
13. Campbell JS, Riehle KJ, Brooling JT, Bauer RL, Mitchell C, Fausto N.
Proinflammatory cytokine production in. liver regeneration is Myd88-
dependent, but independent of Cd14, Tlr2, and Tlr4. J Immunol. 2006;
176:2522–8.
14. Seki E, Tsutsui H, Iimuro Y, Naka T, Son G, Akira S, Kishimoto T, Nakanishi K,
Fujimoto J. Contribution of Toll-like receptor/myeloid differentiation factor
88 signaling to murine liver regeneration. Hepatology. 2005;41:443–50.
15. Vaquero J, Campbell JS, Haque J, McMahan RS, Riehle KJ, Bauer RL, Fausto
N. Toll-like receptor 4 and myeloid differentiation factor 88 provide
mechanistic insights into the cause and effects of interleukin-6 activation in
mouse liver regeneration. Hepatology. 2011;54:597–608.
16. Jiang YL, Beller DI, Frendl G, Graves DT. Monocyte chemoattractant protein-
1 regulates adhesion molecule expression and cytokine production in
human monocytes. J Immunol. 1992;148:2423–8.
17. Low QEH, Drugea IA, Duffner LA, Quinn DG, Cook DN, Rollins BJ, Kovacs EJ,
DiPietro LA. Wound healing in MIP-1 alpha(−/−) and MCP-1(−/−) mice. Am
J Pathol. 2001;159:457–63.
18. Yamaguchi Y, Matsumura F, Takeya M, Ichiguchi O, Kuratsu JI, Horiuchi T,
Akizuki E, Matsuda T, Okabe K, Ohshiro H, et al. Monocyte chemoattractant
protein-1 enhances expression of intercellular adhesion molecule-1 following
ischemia-reperfusion of the liver in rats. Hepatology. 1998;27:727–34.
19. Luster AD. Chemokines - Chemotactic cytokines that mediate inflammation.
N Engl J Med. 1998;338:436–45.
Wyler et al. Journal of Inflammation  (2016) 13:28 Page 7 of 8
20. Czaja MJ, Geerts A, Xu J, Schmiedeberg P, Ju Y. Monocyte chemoattractant
protein-1 (MCP-1) expression occurs in toxic rat liver injury and human liver
disease. J Leukoc Biol. 1994;55:120–6.
21. Marra F, DeFranco R, Grappone C, Milani S, Pastacaldi S, Pinzani M,
Romanelli RG, Laffi G, Gentilini P. Increased expression of monocyte
chemotactic protein-1 during active hepatic fibrogenesis - Correlation with
monocyte infiltration. Am J Pathol. 1998;152:423–30.
22. Marra F. Chemokines in liver inflammation and fibrosis. Front Biosci. 2002;7:
D1899–914.
23. Muhlbauer M, Bosserhoff AK, Hartmann A, Thasler WE, Weiss TS, Herfarth H,
Lock G, Scholmerich J, Hellerbrand C. A novel MCP-1 gene polymorphism is
associated with hepatic MCP-1 expression and severity of HCV-related liver
disease. Gastroenterology. 2003;125:1085–93.
24. Imamura M, Ogawa T, Sasaguri Y, Chayama K, Ueno H. Suppression of
macrophage infiltration inhibits activation of hepatic stellate cells and liver
fibrogenesis in rats. Gastroenterology. 2005;128:138–46.
25. Zamara E, Galastri S, Aleffi S, Petrai I, Aragno M, Mastrocola R, Novo E,
Bertolani C, Milani S, Vizzutti F, et al. Prevention of severe toxic liver injury
and oxidative stress in MCP-1-deficient mice. J Hepatol. 2007;46:230–8.
26. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, North R, Gerard C,
Rollins BJ. Abnormalities in monocyte recruitment and cytokine expression
in monocyte chemoattractant protein 1-deficient mice. J Exp Med. 1998;
187:601–8.
27. Mitchell KA, Lockhart CA, Huang GM, Elferink CJ. Sustained aryl hydrocarbon
receptor activity attenuates liver regeneration. Mol Pharmacol. 2006;70:163–70.
28. Aldeguer X, Debonera F, Shaked A, Krasinkas AM, Gelman AE, Que XG,
Zamir GA, Hiroyasu S, Kovalovich KK, Taub R, Olthoff KM. Interleukin-6 from
intrahepatic cells of bone marrow origin is required for normal murine liver
regeneration. Hepatology. 2002;35:40–8.
29. Hokeness KL, Kuziel WA, Biron CA, Salazar-Mather TP. Monocyte
chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/
beta-induced inflammatory responses and antiviral defense in liver. J
Immunol. 2005;174:1549–56.
30. Hokeness-Antonelli KL, Crane MJ, Dragoi AM, Chu WM, Salazar-Mather TP.
IFN-alpha beta-Mediated inflammatory responses and antiviral Defense in
liver is TLR9-Independent but MyD88-Dependent during murine
cytomegalovirus infection. J Immunol. 2007;179:6176–83.
31. Ajuebor MN, Hogaboam CM, Le T, Swain MG. C-C chemokine ligand 2/
monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4
production and is hepatoprotective in T cell-mediated hepatitis in the
mouse. J Immunol. 2003;170:5252–9.
32. James LP, Simpson PM, Farrar HC, Kearns GL, Wasserman GS, Blumer JL,
Reed MD, Sullivan JE, Hinson JA, Pediat Pharmacology Res Unit N. Cytokines
and toxicity in acetaminophen overdose. J Clin Pharmacol. 2005;45:1165–71.
33. Su AI, Guidotti LG, Pezacki JP, Chisari FV, Schultz PG. Gene expression during
the priming phase of liver regeneration after partial hepatectomy in mice.
Proc Natl Acad Sci U S A. 2002;99:11181–6.
34. Yin S, Wang H, Park O, Wei W, Shen J, Gao B. Enhanced liver regeneration in
IL-10–Deficient mice after partial hepatectomy via stimulating inflammatory
response and activating hepatocyte STAT3. Am J Pathol. 2011;178:1614–21.
35. Sgroi A, Gonelle-Gispert C, Morel P, Baertschiger RM, Niclauss N, Mentha G,
Majno P, Serre-Beinier V, Buhler L. Interleukin-1 receptor antagonist
modulates the early phase of liver regeneration after partial hepatectomy in
mice. PLoS One. 2011;6:e25442. doi:10.1371/journal.pone.0025442.
36. Leifeld L, Purr I, Janberg K, Dumoulin FL, Altfeld M, Sauerbruch T, Spengler
U. Enhanced expression of chemokines correlates with the infiltration of
macrophages in fulminant hepatic failure. Hepatology 1999, 30:547A–547A.
37. Chen XG, Xu CS, Zhang FC, Ma J. Comparative analysis of expression
profiles of chemokines, chemokine receptors, and components of signaling
pathways mediated by chemokines in eight cell types during rat liver
regeneration. Genome. 2010;53:608–18.
38. Crane MJ, Hokeness-Antonelli KL, Salazar-Mather TP. Regulation of
inflammatory monocyte/macrophage recruitment from the bone marrow
during murine cytomegalovirus infection: role for type I interferons in
localized induction of CCR2 ligands. J Immunol. 2009;183:2810–7.
39. Sudo K, Yamada Y, Saito K, Shimizu S, Ohashi H, Kato T, Moriwaki H, Ito H,
Seishima M. TNF-alpha and IL-6 signals from the bone marrow derived cells
are necessary for normal murine liver regeneration. Biochim Biophys Acta.
1782;2008:671–9.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Wyler et al. Journal of Inflammation  (2016) 13:28 Page 8 of 8
